Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

Overview of attention for article published in Cancer Cell International, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

twitter: 1 X user

patent: 8 patents

Citations

dimensions_citation: 196 Dimensions

Readers on

mendeley: 160 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Antibodies against human CD38

Grant US-11230604-B2

United States of America

Therapies for hematologic malignancies

Grant AU-2019213337-C1

Australia

Therapies for hematologic malignancies

Grant AU-2019213337-B2

Australia

ANTI-CD38 PLUS CORTICOSTEROIDS PLUS A NON-CORTICOSTEROID CHEMOTHERAPEUTIC FOR TREATING…

Application EP-2081595-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 4 additional patents.